Vanguard Group Inc. Sells 78,676 Shares of Acadia Healthcare Company, Inc. $ACHC

Key Points

• Vanguard Group Inc. reduced its stake in Acadia Healthcare by 0.9%, selling 78,676 shares, and now owns approximately 9.55% of the company, valued at $266.87 million.
• Acadia Healthcare posted earnings of $0.83 per share, surpassing estimates, with a revenue of $869.23 million during the quarter, representing a 9.2% increase year-over-year.
• Analysts have revised their price targets for Acadia Healthcare between $29.00 and $55.00, with a consensus rating of "Moderate Buy" and an average price target of $40.77.

Vanguard Group Inc. decreased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 0.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,801,781 shares of the company's stock after selling 78,676 shares during the period. Vanguard Group Inc. owned approximately 9.55% of Acadia Healthcare worth $266,870,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Coldstream Capital Management Inc. lifted its stake in Acadia Healthcare by 4.9% during the fourth quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock valued at $257,000 after buying an additional 303 shares in the last quarter. PNC Financial Services Group Inc. boosted its stake in Acadia Healthcare by 10.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company's stock worth $202,000 after purchasing an additional 622 shares during the period. LPL Financial LLC grew its position in Acadia Healthcare by 1.2% during the 1st quarter. LPL Financial LLC now owns 56,527 shares of the company's stock worth $1,651,000 after purchasing an additional 697 shares in the last quarter. Quantinno Capital Management LP raised its stake in Acadia Healthcare by 9.0% during the 4th quarter. Quantinno Capital Management LP now owns 8,695 shares of the company's stock valued at $345,000 after purchasing an additional 721 shares during the period. Finally, UMB Bank n.a. boosted its position in shares of Acadia Healthcare by 149.5% in the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after buying an additional 755 shares during the period.

Acadia Healthcare Stock Performance

ACHC traded up $0.90 during trading on Friday, hitting $22.32. The stock had a trading volume of 1,093,177 shares, compared to its average volume of 2,200,389. The firm has a market cap of $2.06 billion, a PE ratio of 14.75, a P/E/G ratio of 4.19 and a beta of 0.88. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 12 month low of $17.13 and a 12 month high of $82.40. The company has a 50 day simple moving average of $21.89 and a 200-day simple moving average of $26.41.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.71 by $0.12. The business had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. Acadia Healthcare's revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Upgrades and Downgrades

ACHC has been the subject of a number of research reports. Mizuho decreased their price objective on Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating for the company in a research report on Wednesday, August 13th. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. Cowen reiterated a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Raymond James Financial restated an "outperform" rating and issued a $26.00 target price (down previously from $40.00) on shares of Acadia Healthcare in a research note on Thursday, August 14th. Finally, Royal Bank Of Canada reduced their price target on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating for the company in a report on Wednesday, August 13th. Nine equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $40.77.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.